Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background/aims: Although the incidence of nontuberculous mycobacteria pulmonary disease (NTM-PD), a chronic infectious disease, is increasing, lung and gut microbiota dysbiosis in NTM patients has rarely been studied and was therefore the focus of this study.
Methods: We analyzed the microbiota diversity in sputum and stool samples from 10 healthy subjects and 10 patients with NTM-PD through sequencing of the V3 and V4 regions of the 16S rRNA gene. In NTM-PD patients, we comparatively evaluated the microbiota diversity according to the body mass index (BMI), with BMI ≤ 18.5 kg/m2 defined as "underweight" and BMI > 18.5 kg/m2 as "others."
Results: The sputum microbiota from NTM-PD patients tended to have lower index values of amplicon sequence variant richness, Shannon evenness, and beta diversity than those from the control group. Furthermore, NTM-PD patients with a low BMI had a lower microbiota diversity than patients with high BMI. Fecal samples from NTM-PD patients also significantly differed in alpha and beta diversity compared with the control group and exhibited a diversity pattern similar to that found in sputum samples.
Conclusion: Our results reveal that the lung and gut microbiota of patients with NTM-PD exhibit an altered distribution and reduced richness and diversity.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10636543 | PMC |
| http://dx.doi.org/10.3904/kjim.2023.097 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Association between body mass index and the prognosis of community-acquired pneumonia in patients with nontuberculous mycobacterial pulmonary disease: a retrospective cohort study using a nationwide inpatient database.
BMC Infect Dis
August 2025
Department of Clinical Epidemiology and Health Economics, School of Public Health, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Background: Nontuberculous mycobacterial pulmonary disease (NTM-PD) is a chronic, debilitating infection that predominantly affects patients with a low body mass index (BMI) and leads to progressive destruction of lung parenchyma. Although pneumonia is a common cause of death among patients with NTM-PD, information on its prognosis is scarce. We evaluated the association between BMI and outcomes in patients with NTM-PD who were hospitalized for community-acquired pneumonia (CAP).
View Article and Find Full Text PDFDiagnostic accuracy and predictive value of the QuantiFERON-TB gold plus assay for tuberculosis in immunocompromised individuals: a prospective TBnet study.
Lancet Reg Health Eur
October 2025
Clinical Infectious Disease. Department of Clinical Infectious Diseases, Research Center Borstel, Leibniz Lung Center, Borstel, Germany.
Background: In low tuberculosis (TB)-endemic countries, tuberculosis preventive therapy (TPT) is recommended for immunocompromised individuals with a positive immunodiagnostic test. This study aimed to assess the performance of the QuantiFERON-TB Gold Plus (QFT+) assay and predictive power for future tuberculosis in immunocompromised individuals.
Methods: In this prospective observational study, immunocompromised adults ≥18 years of age including people living with HIV (PLHIV), chronic renal failure, rheumatoid arthritis, solid-organ transplantation or stem-cell transplantation, and immunocompetent adults with and without TB-disease were recruited at 21 sites in 11 European countries and tested with the QFT+ assay.
Utility of sputum specimen quality evaluation in improving diagnostic accuracy for Nontuberculous mycobacterium pulmonary disease.
J Infect Chemother
September 2025
Department of Respiratory Medicine, Toho University Omori Medical Center, Japan.
Background: Accurate diagnosis of Nontuberculous mycobacterial pulmonary disease (NTM-PD) depends on the quality of sputum specimens. While assessing sputum purulence may enhance diagnostic accuracy in NTM-PD, its utility has yet to be fully established.
Methods: This single-center retrospective study included 183 patients with NTM-PD.
Non-tuberculous micobacteria in the elderly. Multicentric study.
Respir Med
October 2025
Pneumology Service, Hospital Universitario Cruces, Barakaldo, Bizkaia, Spain; Bioinformatics and Statistics Unit, Biobizkaia Health Research Institute, Barakaldo, Spain. Electronic address:
Background: Nontuberculous mycobacterial (NTM) pulmonary disease is an increasingly common infectious condition that particularly affects patients with pre-existing lung disease, immunosuppression, and the elderly.
Objectives: To determine the incidence of NTM isolation and NTM pulmonary disease (NTM-PD) in older adults and describe their clinical, radiological characteristics, and treatment outcomes.
Methods: A multicenter observational study conducted retrospectively (2012-2017) and prospectively (2018-2020) in five tertiary hospitals in northern Spain.
The spectrum of CFTR dysfunction in patients with nontuberculous mycobacterial pulmonary disease.
Respir Investig
September 2025
Department of Pulmonary Diseases, Research Institute for Medical Innovation, Radboud University Medical Center, Radboudumc Community for Infectious Diseases, PO Box 9101, 6500 HB, Nijmegen, the Netherlands.
Dysfunctional cystic fibrosis transmembrane conductance regulator (CFTR) protein is a potential but undercharacterized risk factor for nontuberculous mycobacterial pulmonary disease (NTM-PD). We reviewed health records to identify clinical features of NTM-PD patients who exhibited CFTR dysfunction, defined by sweat chloride concentration (SCC) ≥30 mmol/L. CFTR genotyping was performed in those with elevated SCC.
View Article and Find Full Text PDF